24 -2 (34) 2021 — Nigmatullaeva M.A. — FEATURES OF CARDIAC ARRHYTHMIAS IN HUMANS WITH METABOLIC SYNDROME

FEATURES OF CARDIAC ARRHYTHMIAS IN HUMANS WITH METABOLIC SYNDROME

Nigmatullaeva M.A.  Bukhara State Medical Institute

Resume

The current concepts are given on metabolic syndrome, criteria of its diagnosis, peculiarities of medical treatment of different components of the metabolic syndrome, as well as the data on its influence on the incidence of cardiac arrhythmias.

Key words: metabolic syndrome, arterial hypertension, diabetes mellitus, insulin resistance, obesity, cardiac arrhythmias, atrial fibrillation.

First page

122

Last page

127

For citation: Nigmatullaeva M.A.  Features of cardiac arrhythmias in humans with metabolic syndrome //New Day in Medicine 2(34)2021 122-127 https://cutt.ly/kb0ecEQ

LIST OF REFERENCES

  1. Gersh B.J., Tsang T.S.M., Seward J.B. The changing ep­idemiology and natural history of nonvalvular atrial fibril­lation: clinical implications. Transaction of the American clinical and climatological association 2014; 115: P.149- 160.
  2. Ash-Bernal R., Peterson L.R. The cardio metabolic syn­drome and cardiovascular disease. //J Cardiometab Syndr 2016;1:25-28.
  3. Umetani K., Kodama Y., Nakamura T. et al. High Preva­lence of Paroxysmal Atrial Fibrillation and/or Atrial Flutter in Metabolic Syndrome. //Circ J 2015; 71:252-255.
  4. Watanabe H., Tanabe N., Watanabe T. et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation. The Niigata Preventive Medicine Study. //Circulation 2014; 117: I255-1260.
  5. Nicolaou V.N., Papadakis J.E., Karatzis F.N. et al. Im­pact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. //Angiology 2016;58 (1):21-25.
  6. Echahidi N., Mohty D., Pibarot P. Obesity and metabol­ic syndrome are independent risk factors for atrial fibrilla­tion after coronary artery bypass graft surgery. //Circulation 2016; 116 (11): I213-1219.
  7. Alpert M.A. Obesity cardiomyopathy: pathophysiol­ogy and evolution of the clinical syndrome. //Am J Med Sci 2016;321 (4):225-236.
  8. Lown B., Verrier R.L. Neural activity and ventricular fibrillation. N Engl J Med 2014; 294(21):1165-1170.
  9. Verrier R.L., Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. //CurrOpinCardiol 2012;19(1):2-11.
  10.  Park S.K., Schwartz J., Weisskopf M. et al. Low-Level Lead Exposure, Metabolic Syndrome, and Heart Rate Vari­ability: The VA Normative Aging Study. //Environ Health Perspect 2014; 114(11): 1718-1724.
  11.  Guidelines for the Management of Arterial Hy­pertension. EHJ 2017; 28: 1462-1536.
  12.  Miranda P.J., DeFronzo R.A., Califf R.M., Gryton J.R. Metabolic syndrome: definition, pathophysiology and mechanisms. //Am Heart J 2015; 149: 33-45.
  13. Ardern C.I., Janssen I., Ross R., Katzmarzyk P.T. De­velopment of health-related waist circumference thresholds within BMI categories. //Obes Res 2014; 12:1094-1103.
  14.  Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. //Part 1: Diabet Med 2017; 15(7): 539-553.
  15.  National Cholesterol Education Program, Adult Treatment Panel III, 2016. //JAMA 2016; 285: 2486-2497.
  16.  Lakka H.M., Laaksonen D.E., Lakka T.A. et al. Themetabolic syndrome and total and cardiovascular disease mortality in middle-aged men. //JAMA 2015; 288: 2709­2716.
  17.  Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. //JAMA. 2015; 16;287(3):356-359.
  18.  Evans R.M., Barish G.D., Wang Y.U. PPARs and the complex journey to obesity. //Nat Med 2013; 10: 355-361.
  19.  Diagnosis and treatment of metabolic syndrome. Russian recommendations. 2013; 6: 1 – 26.
  20.  Kershaw E.E., Flier J.S. Adipose tissue as endocrine organ. //J ClinEndocrinolMetab 2014; 89: 2548-2556.

file

download